Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents
- PMID: 28340987
- DOI: 10.1016/j.bmc.2016.10.022
Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents
Abstract
A series of curcumin derivatives as potent dual inhibitors of xanthine oxidase (XOD) and urate transporter 1 (URAT1) was discovered as anti-hyperuricemic agents. These compounds proved efficient effects on anti-hyperuricemic activity and uricosuric activity in vivo. More importantly, some of them exhibited proved efficient effects on inhibiting XOD activity and suppressing uptake of uric acid via URAT1 in vitro. Especially, the treatment of 4d was demonstrated to improve uric acid over-production and under-excretion in oxonate-induced hyperuricemic mice through regulating XOD activity and URAT1 expression. Docking study was performed to elucidate the potent XOD inhibition of 4d. Compound 4d may serve as a tool compound for further design of anti-hyperuricemic drugs targeting both XOD and URAT1.
Keywords: Anti-hyperuricemic; Curcumin derivatives; Urate transporter 1; Uricosuric; Xanthine oxidase.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.Biomed Pharmacother. 2017 Feb;86:88-94. doi: 10.1016/j.biopha.2016.12.002. Epub 2016 Dec 9. Biomed Pharmacother. 2017. PMID: 27951420
-
Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.Phytomedicine. 2021 Jan;80:153374. doi: 10.1016/j.phymed.2020.153374. Epub 2020 Oct 9. Phytomedicine. 2021. PMID: 33075645
-
Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.J Ethnopharmacol. 2015 Dec 4;175:14-20. doi: 10.1016/j.jep.2015.08.043. Epub 2015 Sep 3. J Ethnopharmacol. 2015. PMID: 26344851
-
Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents.J Med Chem. 2024 Nov 28;67(22):19966-19987. doi: 10.1021/acs.jmedchem.4c01260. Epub 2024 Nov 8. J Med Chem. 2024. PMID: 39513478 Review.
-
Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).Expert Opin Ther Pat. 2019 Nov;29(11):871-879. doi: 10.1080/13543776.2019.1676727. Epub 2019 Oct 14. Expert Opin Ther Pat. 2019. PMID: 31593642 Review.
Cited by
-
Ethanol Extracts from Torreya grandis Seed Have Potential to Reduce Hyperuricemia in Mouse Models by Influencing Purine Metabolism.Foods. 2024 Mar 9;13(6):840. doi: 10.3390/foods13060840. Foods. 2024. PMID: 38540830 Free PMC article.
-
Recent Advances in Xanthine Oxidase Inhibitors.Mini Rev Med Chem. 2024;24(12):1177-1186. doi: 10.2174/1389557523666230913091558. Mini Rev Med Chem. 2024. PMID: 37711003 Review.
-
Phytochemical compounds for treating hyperuricemia associated with gout: a systematic review.Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4779-4801. doi: 10.1007/s00210-024-03686-4. Epub 2024 Dec 5. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39636406
-
Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure-Activity Relationships.Molecules. 2022 Sep 26;27(19):6340. doi: 10.3390/molecules27196340. Molecules. 2022. PMID: 36234878 Free PMC article. Review.
-
Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.Front Immunol. 2022 Jul 22;13:891822. doi: 10.3389/fimmu.2022.891822. eCollection 2022. Front Immunol. 2022. PMID: 35935936 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information